Page 26 - Anjali Singh

Pharma companies on track with QR codes to combat counterfeit drugs

Firms term DCGI move 'positive' as it aims at ensuring patient safety

CEAT Q1 results: Profit rises 2.74% to Rs 149.79 cr, revenue up 8.79%

On a sequential basis, the company exhibited a 6.73 per cent increase in revenue, along with PAT, which also rose by 32.04 per cent

Lupin and Huons partner to bring novel dry eye treatment to Mexico

Cyclosporine Ophthalmic Nanoemulsion is a preservative-free treatment for dry eye syndrome and healing corneal ulcers

Zydus announces licensing deal with Takeda for new GERD drug Vault

Vault works by inhibiting the production of stomach acid and is approved by the Drugs Controller General of India (DCGI) for the treatment of reflux esophagitis and other acid peptic disorders (APDs)

Pharma and healthcare sector seals $4.1 bn deals in Q2 2024: Report

The average deal size also saw a jump, rising from $9.7 million in Q1 calendar year 2024 to $74 million in Q2 2024

Cipla receives additional Rs 773.44 crore tax demand from income tax office

Cipla's share price declined by 0.56 per cent, ending the day's trade at Rs 1,507.50 apiece on the BSE

Auto ancillaries bet on e-mobility to drive growth in FY25: Analysts

Analysts predict moderation in growth to 5-7% in FY25

Godrej Consumer Products develops indigenous mosquito repellent molecule

GCPL holds exclusive rights to use Renofluthrin in its products for six to eight years

Indian auto component industry growth to moderate in FY25, says ICRA

ICRA also expects the industry to invest Rs 20,000-25,000 crore in FY2025 for capacity expansion and technological advancements

Glenmark Pharmaceuticals to sell 7.84% stake in Glenmark Life Sciences

The specific price and date of the offer for sale will likely be announced in the future

Tata Motors, M&M slash prices to boost demand amid unsold inventory

Move came a day after UP government waived registration fees on strong hybrid cars

Salaried professionals drive up sales of pre-owned cars in Q2 of 2024

The most popular car models among buyers included the Hyundai Grand i10, Maruti Suzuki Swift, and Baleno

Tata Motors Group reports 2% increase in Q1 FY25 global wholesales

CV sales up, passenger vehicles dip slightly; JLR growth strong

Massive monsoon season discounts take the wheel in car sales drive

As the monsoon season begins, carmakers and dealers are intensifying their efforts to attract buyers with various incentives, including discounts, exchange bonuses, and assured gifts

Comeback in hospital space: KKR picks up 70% in BMH for Rs 2K crore

KKR's investment aims to support BMH's expansion plans to build a pan-India network of hospitals. This growth will be driven by both organic development and strategic acquisitions

USFDA highlights quality concerns over drugs manufactured in India

USFDA launches QMM program to reduce drug shortages and improve supply chain issues

Indian firms fared better in USFDA inspections in recent years, says IPA

IPA bats for Revised Schedule M implementation as key to pharma manufacturing quality in India

Shifting gears: Ather Energy plans new facility in Maharashtra's Bidkin

The company aims to diversify manufacturing base to enhance proximity to key markets across India and streamline operational costs

Dr. Reddy's to acquire Haleon's nicotine replacement biz for 500 mn pounds

The acquisition includes Nicotinell, a global leader in the NRT category, and its local market-leading brand names Nicabate, Habitrol, and Thrive

RR Global-backed BGauss aims for major EV market share riding on RUV350

The company envisions EV-2W category will maintain a 60 per cent market share by 2030, with the RUV category capturing around 25 to 30 per cent of the market